{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:26:11Z","timestamp":1790108771254,"version":"4.0.1"},"reference-count":0,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJV"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5501\/wjv.v4.i3.178","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T03:36:02Z","timestamp":1439350562000},"page":"178","source":"Crossref","is-referenced-by-count":5,"title":["Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?"],"prefix":"10.5501","volume":"4","author":[{"given":"Tatsuo","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","container-title":["World Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/2220-3249\/full\/v4\/i3\/178.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T03:36:05Z","timestamp":1439350565000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2220-3249\/full\/v4\/i3\/178.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5501\/wjv.v4.i3.178","relation":{},"ISSN":["2220-3249"],"issn-type":[{"value":"2220-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}